Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet.
Sato M, Han Q, Mizuta K, Mori R, Kang BM, Morinaga S, Kobayashi N, Ichikawa Y, Nakajima A, Hoffman RM. Sato M, et al. Among authors: nakajima a. In Vivo. 2024 May-Jun;38(3):1459-1464. doi: 10.21873/invivo.13591. In Vivo. 2024. PMID: 38688589 Free PMC article.
Pre-emptive hydration with lactated Ringer's solution could reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in at-risk patients: Propensity score-matched analysis.
Kurita Y, Suzuki K, Yagi S, Hasegawa S, Sato T, Hosono K, Kobayashi N, Endo I, Kubota K, Nakajima A. Kurita Y, et al. Among authors: nakajima a. J Hepatobiliary Pancreat Sci. 2023 Jun;30(6):777-783. doi: 10.1002/jhbp.1267. Epub 2022 Nov 23. J Hepatobiliary Pancreat Sci. 2023. PMID: 36349478
Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer.
Sato M, Han Q, Kubota Y, Baranov A, Ardjmand D, Mizuta K, Morinaga S, Kang BM, Kobayashi N, Bouvet M, Ichikawa Y, Nakajima A, Hoffman RM. Sato M, et al. Among authors: nakajima a. Anticancer Res. 2024 Jan;44(1):31-35. doi: 10.21873/anticanres.16785. Anticancer Res. 2024. PMID: 38159986
Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet.
Sato M, Han Q, Mori R, Mizuta K, Kang BM, Morinaga S, Kobayashi N, Ichikawa Y, Nakajima A, Hoffman RM. Sato M, et al. Among authors: nakajima a. Anticancer Res. 2024 Apr;44(4):1499-1504. doi: 10.21873/anticanres.16946. Anticancer Res. 2024. PMID: 38538002
Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model.
Sato M, Mizuta K, Han Q, Morinaga S, Kang BM, Kubota Y, Mori R, Baranov A, Kobayashi K, Ardjmand D, Kobayashi N, Bouvet M, Ichikawa Y, Nakajima A, Hoffman RM. Sato M, et al. Among authors: nakajima a. In Vivo. 2024 May-Jun;38(3):1058-1063. doi: 10.21873/invivo.13539. In Vivo. 2024. PMID: 38688611 Free PMC article.
First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease.
Sato M, Han Q, Hozumi C, Kujiraoka H, Mizuta K, Morinaga S, Kang BM, Kobayashi N, Ichikawa Y, Nakajima A, Hoffman RM. Sato M, et al. Among authors: nakajima a. Anticancer Res. 2024 Sep;44(9):3885-3889. doi: 10.21873/anticanres.17215. Anticancer Res. 2024. PMID: 39197890
[11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients.
Sato M, Sato T, Hozumi C, Han Q, Mizuta K, Morinaga S, Kang BM, Kobayashi N, Ichikawa Y, Nakajima A, Hoffman RM. Sato M, et al. Among authors: nakajima a. Anticancer Res. 2024 Sep;44(9):3891-3898. doi: 10.21873/anticanres.17216. Anticancer Res. 2024. PMID: 39197923
2,200 results